The COVID-19 pandemic has burdened most of the health systems around the world. Governments, especially in resource-constrained low- and middle-income countries, are finding it hard to meet the health needs of their nationals. Patent exclusive rights further add to the cost of healthcare by allowing supra-competitive prices of protected technologies. Parallel importation of patented health technologies is a legitimate policy option to obtain patented health technologies at a reduced price. This paper examines the legality and practical significance of parallel trade of patented medicines as a price-reducing policy option and evaluates some of the practical hurdles in the actual use of this important public health flexibility. This study supports the adoption of international exhaustion of patent rights as a mandatory rule for the international trading system.
HoC. Access to medicine in the global economy: international agreements on patents and related rights. Oxford: Oxford University Press, 2011, p. 7.
4.
LinnosmaaIKarhunenTVohlonenI.Parallel importation of pharmaceuticals in Finland. Pharmaceut Dev Regulat2003; 1: 68.
5.
KurpadMR.The crack in the wall: parallel importation as a flexibility within the Indian patent system to ensure access to medicine.Indian J Intell Prop L2014; 7: 32.
6.
OwoeyeO.Access to medicines and parallel trade in patented pharmaceuticals. Eur Intell Prop Rev2015; 37: 360.
7.
KurpadMR.The crack in the wall: parallel importation as a flexibility within the Indian patent system to ensure access to medicine.Indian J Intell Prop L2014; 7, 40.
8.
OwoeyeO.Access to medicines and parallel trade in patented pharmaceuticals. Eur Intell Prop Rev2015; 37: 364.
9.
The Agreement on Trade-Related Aspects of Intellectual Property Rights 1995 art. 6.
10.
Doha ministerial declaration on TRIPS agreement and public health2001, Para 5(d).
11.
The patents (amendment) act 2005 (India), s 107A.
12.
GhoshSCalboliI.Exhausting intellectual property rights: a comparative law and policy analysis. Cambridge: Cambridge University Press, 2018, p. 109.
13.
RagavanSFlynnSBakerB.Justifying India’s patent position to the United States International Trade Commission and Office of the United States Trade Representative. Indian J Intell Prop L2014; 7: 18.
14.
BasheerSKochupillaiM.‘Exhausting’ patent rights in India: parallel imports and TRIPS compliance. J Intell Prop Rights2008; 13: 489.
15.
LinnosmaaIKarhunenTVohlonenI.Parallel importation of pharmaceuticals in Finland. Pharm Dev Regul2003; 1: 72.
16.
FlintAPayneJ.Intellectual property rights and the potential for universal access to treatment: trips, acta and HIV/AIDS medicine. Third World Q2013; 34: 507.
17.
AbbottF.M. Parallel trade in pharmaceuticals: trade therapy for market distortions. In: Irene C and Edward L (eds) Research handbook on intellectual property exhaustion and parallel imports. Cheltenham: Edward Elgar Publishing, 2016, p. 146.
18.
SundaramJ.Pharmaceutical patent protection and world trade law: the unresolved problem of access to medicines. Milton Park: Routledge, 2018, p. 176.
19.
SundaramJ.Pharmaceutical patent protection and world trade law: the unresolved problem of access to medicines. Milton Park: Routledge, 2018, p. 175.
20.
SundaramJ.Pharmaceutical patent protection and world trade law: the unresolved problem of access to medicines. Milton Park: Routledge, 2018, p. 177.
21.
What is the U.S. role in combating the global HIV/AIDS epidemic?: hearing before the subcommittee on criminal justice, during policy, and human resources of the committee on government reform, house of representatives, One Hundred Sixth Congress, United States House of Representatives, Committee on Government Reform, and United States Congress. First Session, 22 July 1999.
22.
1999 Special 301 Report (30 April 1999) Office of the U.S. Trade Representative. United States House of Representatives, Committee on Government Reform, and United States Congress.
23.
YuPK.Access to medicines, BRICS alliances, and collective action. Am J Law Med2008; 34: 355.
24.
MatthewsD.Intellectual property, human rights, and development: the role of NGOs and social movements. Cheltenham: Edward Elgar Publishing, 2011, p. 99.
25.
SundaramJ.Pharmaceutical patent protection and world trade law: the unresolved problem of access to medicines. Milton Park: Routledge, 2018, p. 178.
AbbottFM. Parallel trade in pharmaceuticals: trade therapy for market distortions. In Irene C and Edward L (eds) Research handbook on intellectual property exhaustion and parallel imports. Cheltenham: Edward Elgar Publishing, 2016, pp. 151–152.
28.
AbbottFM. Parallel trade in pharmaceuticals: trade therapy for market distortions. In Research handbook on intellectual property exhaustion and parallel imports. Cheltenham: Edward Elgar Publishing, 2016, p. 147.
29.
RajecSRW.Free trade in patented goods: international exhaustion for patents. Berkeley Technol Law J2014; 355: 317–376.
30.
United States-Morocco Free Trade Agreement, Art. 15.9(4), 15 June 2004.
31.
United States-Australia Free Trade Agreement, Art. 17.9(4), 1 January 2005.
